Covestor’s Organogenesis Holdings ORGO Stock Holding History

Covestor’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	20	–	–	﹤0.01%	2635
2025 Q4	$0	Hold	20	–	–	﹤0.01%	2609
2025 Q3	$0	Hold	20	–	–	﹤0.01%	2624
2025 Q2	$0	Sell	20 -1	-5%	-$4	﹤0.01%	2597
2025 Q1	$0	Hold	21	–	–	﹤0.01%	2585
2024 Q4	$0	Buy	21 +1	+5%	+$3	﹤0.01%	2592
2024 Q3	$0	Sell	20 -1	-5%	-$3	﹤0.01%	2596
2024 Q2	$0	Hold	21	–	–	﹤0.01%	2607
2024 Q1	$0	Sell	21 -2	-9%	-$7	﹤0.01%	2595
2023 Q4	$0	Sell	23 -2	-8%	-$6	﹤0.01%	2547
2023 Q3	$0	Sell	25 -26	-51%	-$83	﹤0.01%	2535
2023 Q2	$0	Buy	51 +28	+122%	+$83	﹤0.01%	2494
2023 Q1	$0	Hold	23	–	–	﹤0.01%	2418
2022 Q4	$0	Sell	23 -1	-4%	-$3	﹤0.01%	2445
2022 Q3	$0	Sell	24 -132	-85%	-$596	﹤0.01%	2411
2022 Q2	$1K	Buy	156 +47	+43%	+$289	﹤0.01%	1775
2022 Q1	$1K	Buy	109 +28	+35%	+$217	﹤0.01%	1909
2021 Q4	$1K	Buy	+81	New	+$860	﹤0.01%	1871

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Covestor's ORGO Position: Q1 2026 in Review

Covestor held its Organogenesis Holdings (ORGO) position steady in Q1 2026 at 20 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

Covestor first reported a position in ORGO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1K in Q2 2022. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Covestor held 20 shares of Organogenesis Holdings worth $0 as of Q1 2026.
Covestor left its Organogenesis Holdings share count unchanged in Q1 2026.
Organogenesis Holdings made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2635 holding.
Covestor first reported a position in Organogenesis Holdings in Q4 2021 and has held it in 18 quarters since.
Covestor's Organogenesis Holdings position peaked at $1K in Q2 2022.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.